ADMOVID Trademark

Trademark Overview

On Monday, March 5, 2012, a trademark application was filed for ADMOVID with the United States Patent and Trademark Office. The USPTO has given the ADMOVID trademark a serial number of 85559983. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 7, 2015. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The ADMOVID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of the deficiency or absence of naturally produced testosterone
admovid

General Information

Serial Number85559983
Word MarkADMOVID
Filing DateMonday, March 5, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 7, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of the deficiency or absence of naturally produced testosterone

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 11, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 194541090

Trademark Events

Event DateEvent Description
Tuesday, September 8, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 7, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 16, 2014EXTENSION 5 GRANTED
Tuesday, December 16, 2014EXTENSION 5 FILED
Tuesday, December 16, 2014TEAS EXTENSION RECEIVED
Tuesday, May 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 16, 2014EXTENSION 4 GRANTED
Friday, May 16, 2014EXTENSION 4 FILED
Friday, May 16, 2014TEAS EXTENSION RECEIVED
Tuesday, December 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 7, 2013EXTENSION 3 GRANTED
Saturday, December 7, 2013EXTENSION 3 FILED
Saturday, December 7, 2013TEAS EXTENSION RECEIVED
Friday, June 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2013EXTENSION 2 GRANTED
Wednesday, June 19, 2013EXTENSION 2 FILED
Wednesday, June 19, 2013TEAS EXTENSION RECEIVED
Thursday, December 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 11, 2012EXTENSION 1 GRANTED
Tuesday, December 11, 2012EXTENSION 1 FILED
Tuesday, December 11, 2012TEAS EXTENSION RECEIVED
Tuesday, August 7, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 12, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 9, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 9, 2012ASSIGNED TO LIE
Monday, April 23, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 23, 2012ASSIGNED TO EXAMINER
Sunday, March 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 8, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

admovid naturally produced testosterone absence deficiency preparations treatment pharmaceutical